Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Gabriella Captur Added: 6 months ago
Discover different imaging options for the diagnosis of cardiomyopathies from Dr Gabriella Captur (Royal Free London NHS Foundation Trust, London, UK).This two-part video lecture series, part of Women As One's CLIMB® 2025 Skills Training Program, provides a comprehensive overview of key treatments and therapy approaches to cardiomyopathies.Dr Captur explores cardiac imaging techniques for the… View more
Author(s): Vasvi Singh Added: 5 months ago
Navigate the diagnostic complexities of cardiac amyloidosis through expert multimodality imaging techniques with Dr Vasvi Singh.This comprehensive presentation, part of the Cardiomyopathies track, addresses the critical role of advanced imaging in diagnosing cardiac amyloidosis. Dr Singh explores the nuanced differences between SPECT and SPECT-CT imaging capabilities, providing practical insights… View more
Author(s): Victoria Delgado , Clara Saldarriaga Added: 8 months ago
In this expert clinical discussion, join Prof Victoria Delgado as she discusses her manuscript on multimodality imaging approaches in hypertrophic cardiomyopathy (HCM). Dr Clara Saldarriaga, Guest Editor of the HCM special focus collection, facilitates this in-depth conversation exploring how different imaging techniques enhance diagnosis, phenotyping, and risk stratification in HCM patients.The… View more
Author(s): Emer Joyce Added: 2 months ago
Explore the diagnostic and therapeutic complexities of cardiac sarcoidosis with Prof Emer Joyce.This presentation, part of the comprehensive Cardiomyopathies track, tackles the persistent challenges in cardiac sarcoidosis, emphasizing that despite decades of clinical experience, diagnosis remains the field's greatest hurdle.Prof Joyce explores the heterogeneous clinical phenotypes capable of… View more
Author(s): Added: 3 months ago
AHA Scientific Sessions 2025 - Dr Sarah Cuddy (Brigham and Women's Hospital, US) joins us to discuss the role of non-disease modifying treatments including SGLT2 inhibitors, mineralocorticoid receptor antagonists, GLP-1 receptor agonists, and implantable hemodynamic monitors in cardiac amyloidosis, and what this means for managing heart failure in this unique patient population.Interview… View more
Author(s): Added: 5 months ago
Discover the rapidly evolving therapeutic options transforming outcomes for cardiac amyloidosis patients with Dr Sarah Cuddy.This comprehensive presentation, part of the Cardiomyopathies track, explores the dramatic advances in both TTR and AL amyloidosis treatment over the past decade. Dr Cuddy examines how modern therapeutic approaches have fundamentally shifted survival curves, particularly… View more